KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Accounts Payables (2016 - 2025)

West Pharmaceutical Services' Accounts Payables history spans 17 years, with the latest figure at $253.7 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 6.02% year-over-year to $253.7 million; the TTM value through Dec 2025 reached $253.7 million, up 6.02%, while the annual FY2025 figure was $253.7 million, 6.02% up from the prior year.
  • Accounts Payables for Q4 2025 was $253.7 million at West Pharmaceutical Services, down from $255.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $255.8 million in Q3 2025 and bottomed at $188.9 million in Q3 2022.
  • The 5-year median for Accounts Payables is $226.4 million (2024), against an average of $226.4 million.
  • The largest annual shift saw Accounts Payables increased 29.39% in 2021 before it fell 9.05% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $232.2 million in 2021, then fell by 7.24% to $215.4 million in 2022, then rose by 12.53% to $242.4 million in 2023, then decreased by 1.28% to $239.3 million in 2024, then grew by 6.02% to $253.7 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Accounts Payables are $253.7 million (Q4 2025), $255.8 million (Q3 2025), and $239.0 million (Q2 2025).